首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2011年 4期 => 肝胆胰肿瘤 =>肝细胞癌患者血清胸腺素β4水平
肝细胞癌患者血清胸腺素β4水平
Serum thymosin β4 level in patients with hepatocellular carcinoma
文章发布日期:2011年04月03日  来源:  作者:邢 晶 韩 涛 朱争艳等  点击次数:3806次  下载次数:834次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的 检测肝细胞癌(HCC)患者血清胸腺素β4(Tβ4)水平及其影响因素。方法 采用ELISA方法检测80例HCC患者血 清Tβ4水平,并与40例健康人及30例肝硬化患者比较。同时比较不同肿瘤情况及肝功能对HCC组患者血清Tβ4浓度的影响。结 果 HCC患者及肝硬化患者血清Tβ4水平均低于健康人,差异有统计学意义(χ 2=81.228,P<0.001)。按照BCLC分期或CLIP分 期将HCC患者分别分为4个或6个亚组,血清Tβ4浓度差异均有统计学意义(χ 2 =8.669~13.675,P<0.034)。HCC患者中有肝内 转移组血清Tβ4浓度高于无肝内转移组,差异有统计学意义(Z=2.264,P=0.024);有门脉瘤栓组血清Tβ4浓度高于无门脉瘤栓 组,差异有统计学意义(Z=2.574,P=0.010)。无肝内转移而且无远处转移的HCC患者按照肝功能Child-Pugh评分分为A、B、C级 3组,血清Tβ4浓度差异有统计学意义(χ 2=6.467,P=0.039)。结论 肝细胞癌患者血清Tβ4浓度低于健康人,且肝功能越差, 血清Tβ4浓度越低。而发生肝内转移或门脉瘤栓的患者血清Tβ4浓度高于未发生者。
【Abstract】:Objective To investigate serum thymosin β4 (Tβ4) level in patients with hepatocellular carcinoma (HCC). Methods Serum Tβ4 level were measured in 80 patients with HCC, 40 patients with cirrhosis and 40 healthy controls. Serum Tβ4 level were measured by enzyme-linked immunosorbent assay(ELISA). Level of serum Tβ4 in different stages of HCC were compared. Patients with HCC were divided into groups according with or without interhepatic metastasis, portal vein tumor thrombus and distant metastasis and then compared. Results Compared with that in healthy controls, serum Tβ4 level in patients with HCC and cirrhosis was lower with statistically significant difference(χ 2=81.228, P<0.001). Patients with HCC had divided into group A, B, C and D according their BCLC stage. Level of Tβ4 in these 4 groups was statistically significant difference (χ 2=8.669, P=0.034). Patients with HCC were divided into group 0, 1, 2, 3, 4 and 5 according CLIP score. Level of Tβ4 in these 6 groups had statistically significant difference(χ 2=13.675, P=0.018). Meanwhile, Patients with HCC were also divided according interhepatic metastasis, portal vein tumor thrombus and distant metastasis. Serum Tβ4 level was higher in patients with interhepatic metastasis than that in those without metastasis(Z=2.264, P=0.024). Serum Tβ4 level was higher in patients with portal vein tumor thrombus than that in those without tumor thrombus(Z=2.574, P=0.010). Patients who developed neither portal vein tumor thrombus nor distant metastasis were divided into group A, B and C according Childpugh grade and there was statistically significant difference (χ 2=6.467, P=0.039). Conclusion Serum Tβ4 level in patients with HCC were lower than that in healthy controls. And serum Tβ4 level in patients with interhepatic metastasis or portal vein tumor thrombus was higher than that in patients without those diseases.
【关键字】:癌,肝细胞;胸腺素
【Key words】:carcinoma, hepatocellular; thymosin
【引证本文】:

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号